RhumbLine Advisers’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-22,122
| Closed | -$250K | – | 3165 |
|
|
2022
Q1 | $250K | Buy |
22,122
+5,182
| +31% | +$58.6K | ﹤0.01% | 2698 |
|
|
2021
Q4 | $162K | Buy |
16,940
+1,616
| +11% | +$15.5K | ﹤0.01% | 2879 |
|
|
2021
Q3 | $136K | Buy |
15,324
+1,165
| +8% | +$10.3K | ﹤0.01% | 2963 |
|
|
2021
Q2 | $174K | Buy |
+14,159
| New | +$174K | ﹤0.01% | 2932 |
|
|
2019
Q2 | – | Sell |
-905
| Closed | -$7K | – | 2989 |
|
|
2019
Q1 | $7K | Sell |
905
-39
| -4% | -$302 | ﹤0.01% | 2939 |
|
|
2018
Q4 | $7K | Buy |
944
+308
| +48% | +$2.28K | ﹤0.01% | 2974 |
|
|
2018
Q3 | $7K | Sell |
636
-33
| -5% | -$363 | ﹤0.01% | 2918 |
|
|
2018
Q2 | $183K | Buy |
+669
| New | +$183K | ﹤0.01% | 2756 |
|
|
2017
Q2 | – | Sell |
-642
| Closed | -$103K | – | 2936 |
|
|
2017
Q1 | $103K | Buy |
642
+28
| +5% | +$4.49K | ﹤0.01% | 2775 |
|
|
2016
Q4 | $107K | Sell |
614
-153
| -20% | -$26.7K | ﹤0.01% | 2788 |
|
|
2016
Q3 | $188K | Buy |
767
+8
| +1% | +$1.96K | ﹤0.01% | 2700 |
|
|
2016
Q2 | $188K | Buy |
759
+272
| +56% | +$67.4K | ﹤0.01% | 2770 |
|
|
2016
Q1 | $177K | Buy |
487
+36
| +8% | +$13.1K | ﹤0.01% | 2769 |
|
|
2015
Q4 | $208K | Buy |
451
+96
| +27% | +$44.3K | ﹤0.01% | 2776 |
|
|
2015
Q3 | $57K | Buy |
355
+13
| +4% | +$2.09K | ﹤0.01% | 2988 |
|
|
2015
Q2 | $289K | Buy |
+342
| New | +$289K | ﹤0.01% | 2680 |
|